Enhabit (NYSE:EHAB) Reaches New 12-Month High – Here’s What Happened

Enhabit, Inc. (NYSE:EHAB)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $13.68 and last traded at $13.6650, with a volume of 656213 shares traded. The stock had previously closed at $13.66.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Jefferies Financial Group cut shares of Enhabit from a “buy” rating to a “hold” rating and boosted their price objective for the company from $12.50 to $13.80 in a research note on Monday, February 23rd. Leerink Partners raised their price target on shares of Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a report on Monday, February 23rd. TD Cowen restated a “hold” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Friday, March 6th. Citigroup reaffirmed a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Finally, Truist Financial set a $13.80 price objective on Enhabit in a research report on Monday, February 23rd. Two equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $13.57.

Enhabit Stock Up 0.0%

The company has a debt-to-equity ratio of 0.76, a current ratio of 1.63 and a quick ratio of 1.63. The company has a fifty day moving average price of $12.09 and a 200 day moving average price of $9.87. The company has a market cap of $693.09 million, a PE ratio of -151.83 and a beta of 1.56.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million during the quarter, compared to analyst estimates of $270.56 million. As a group, analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Activity

In other news, EVP Julie Diane Jolley sold 2,793 shares of Enhabit stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the completion of the sale, the executive vice president directly owned 139,923 shares of the company’s stock, valued at approximately $1,907,150.49. The trade was a 1.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 3.40% of the company’s stock.

Institutional Investors Weigh In On Enhabit

Large investors have recently added to or reduced their stakes in the company. 8 Knots Management LLC boosted its holdings in shares of Enhabit by 20.5% in the 4th quarter. 8 Knots Management LLC now owns 5,084,714 shares of the company’s stock worth $46,881,000 after purchasing an additional 865,868 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Enhabit by 8.2% during the 3rd quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock valued at $27,178,000 after buying an additional 256,559 shares in the last quarter. Geode Capital Management LLC lifted its position in Enhabit by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 1,187,434 shares of the company’s stock worth $10,951,000 after buying an additional 11,583 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Enhabit by 30.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 866,539 shares of the company’s stock worth $7,989,000 after buying an additional 201,269 shares during the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new stake in Enhabit in the fourth quarter worth approximately $7,567,000.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.